Erratum to: Chordoma: The Quest for Better Treatment Options

Yazar: Heery, Christopher R.
Yayımlandı Oncol Ther (2016)

Chordoma: The Quest for Better Treatment Options

Yazar: Heery, Christopher R.
Yayımlandı Oncol Ther (2016)

Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity

Yazar: Madan, Ravi A, Heery, Christopher R., Gulley, James L.
Baskı/Yayın Bilgisi 2012

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients

Yazar: Madan, Ravi A, Heery, Christopher R, Gulley, James L
Baskı/Yayın Bilgisi 2014

Therapeutic Vaccines and Immunotherapy in Castration-Resistant Prostate Cancer: Current Progress and Clinical Applications

Yazar: Gulley, James L., Madan, Ravi A., Heery, Christopher R.
Yayımlandı Am Soc Clin Oncol Educ Book (2013)

Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers

Yazar: Rajan, Arun, Kim, Chul, Heery, Christopher R., Guha, Udayan, Gulley, James L.
Yayımlandı Hum Vaccin Immunother (2016)

Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer

Yazar: Burotto, Mauricio, Singh, Nishith, Heery, Christopher R., Gulley, James L., Madan, Ravi A.
Yayımlandı Front Oncol (2014)

Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?

Yazar: Fenerty, Kathleen E., Patronas, Nicholas J., Heery, Christopher R., Gulley, James L., Folio, Les R.
Yayımlandı J Digit Imaging (2015)

Antibody-dependent cellular cytotoxicity (ADCC) activity of a novel anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells

Yazar: Boyerinas, Benjamin, Jochems, Caroline, Fantini, Massimo, Heery, Christopher R., Gulley, James L., Tsang, Kwong Yok, Schlom, Jeffrey
Yayımlandı Cancer Immunol Res (2015)

Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

Yazar: Fenerty, Kathleen E., Folio, Les R., Patronas, Nicholas J., Marté, Jennifer L., Gulley, James L., Heery, Christopher R.
Yayımlandı BMC Cancer (2016)

Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab

Yazar: Fujii, Rika, Friedman, Eitan R., Richards, Jacob, Tsang, Kwong Y., Heery, Christopher R., Schlom, Jeffrey, Hodge, James W.
Yayımlandı Oncotarget (2016)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody

Yazar: Boyerinas, Benjamin, Jochems, Caroline, Hance, Kenneth W, Heery, Christopher R, Gulley, James L, Sabzevari, Helen, Schlom, Jeffrey, Tsang, Kwong
Yayımlandı J Immunother Cancer (2014)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine

Yazar: Farsaci, Benedetto, Jochems, Caroline, Grenga, Italia, Donahue, Renee N, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Schlom, Jeffrey
Baskı/Yayın Bilgisi 2013

PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients

Yazar: Lepone, Lauren, Donahue, Renee N, Grenga, Italia, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Schlom, Jeffrey, Farsaci, Benedetto
Yayımlandı J Immunother Cancer (2014)

Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression

Yazar: Grenga, Italia, Lepone, Lauren, Donahue, Renee, Richards, Jacob, Metenou, Simon, Heery, Christopher R, Madan, Ravi, Gulley, James L, Schlom, Jeffrey
Yayımlandı J Immunother Cancer (2015)

The impact of leukapheresis on immune-cell number and function in patients with advanced cancer

Yazar: Gulley, James L., Marté, Jennifer, Heery, Christopher R., Madan, Ravi A., Steinberg, Seth M., Leitman, Susan F., Tsang, Kwong Y., Schlom, Jeffrey
Yayımlandı Cancer Immunol Immunother (2015)

Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)

Yazar: Donahue, Renee N, Grenga, Italia, Lepone, Lauren, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Rodell, Timothy C, Schlom, Jeffrey, Farsaci, Benedetto
Yayımlandı J Immunother Cancer (2014)

Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

Yazar: Donahue, Renee N., Lepone, Lauren M., Grenga, Italia, Jochems, Caroline, Fantini, Massimo, Madan, Ravi A., Heery, Christopher R., Gulley, James L., Schlom, Jeffrey
Yayımlandı J Immunother Cancer (2017)

Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell...

Yazar: Lepone, Lauren M., Donahue, Renee N., Grenga, Italia, Metenou, Simon, Richards, Jacob, Heery, Christopher R., Madan, Ravi A., Gulley, James L., Schlom, Jeffrey
Yayımlandı J Circ Biomark (2016)

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells

Yazar: Lepone, Lauren, Donahue, Renee, Grenga, Italia, Jochems, Caroline, Tsang, Kwong-Yok, Metenou, Simon, Richards, Jacob, Heery, Christopher R, Madan, Ravi, Gulley, James L, Schlom, Jeffrey
Yayımlandı J Immunother Cancer (2015)